And good afternoon, and welcome everyone to the Relmada Therapeutics, Inc. Third Quarter 2025 Conference Call. 2025 is ...

According to a filing with the Securities and Exchange Commission dated Nov. 13, 2025, Wolf Hill Capital Management reduced ...

Consumer goods conglomerate Spectrum Brands ( SPB +9.79%) had a mixed fiscal fourth quarter of 2025 as detailed in the ...

Net Dollar Retention (NDR): The percentage of recurring revenue retained from existing customers over a period, including ...

Join us as we dissect SentinelOne's stock performance and future potential in the competitive cybersecurity landscape. Can ...

Clinical Outcomes -- Twelve-month study data for the Catamaran implant showed VAS scores decreased from 78.8 to 23, and ODI ...

Research and development expense in fiscal Q3 2025 -- $4.5 million versus $4.9 million in fiscal Q3 2024. Net loss -- $5.9 ...

Rule of 30 to 40 Trajectory -- Management expects the combined company could approach the sum of revenue growth rate plus ...

In Jim Cramer's "Stop Trading" segment on CNBC's Squawk on the Street program, the famous stock picker mentioned Amgen ...

Florida Expansion -- Delegated capitation agreement with Elevance Health expanded in Q4 to include additional Medicare ...

IonQ also continues to burn cash, with negative operating cash flow of $208.7 million through the first nine months of the ...

Non-automotive growth -- Expanded commercial traction in off-road autonomy (e.g., Caterpillar, Forterra), aerospace (Lake ...